Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Girma

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|October 22, 1990
Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein IbJ P Girma, Y Takahashi, A Yoshioka, et al.
Blood|September 6, 2001
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 casesA Veyradier, B Obert, A Houllier, et al.
British Journal of Haematology|February 1, 1981
Immunoradiometric assay of factor VIII: coagulant antigen using four human antibodies. Study of 27 cases of haemophilia AJ P Girma, J M Lavergne, D Meyer, et al.
Biochemistry|June 3, 1986
Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domainJ P Girma, M W Chopek, K Titani, et al.
British Journal of Haematology|January 1, 1982
Precipitating anti-VIII:C antibodies in two patients with haemophilia AJ M Lavergne, D Meyer, J P Girma, et al.
Blood|October 1, 1989
New variant of von Willebrand disease with defective binding to factor VIIIM Nishino, J P Girma, C Rothschild, et al.
Blood|February 1, 1984
Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIIIY Laurian, J P Girma, T Lambert, et al.
Thrombosis and Haemostasis|February 1, 1997
Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIIIS Bellucci, J P Girma, M Lozano, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesisA L Jumilly, A Veyradier, A S Ribba, et al.
Blood|September 1, 1987
Structure-function relationship of human von Willebrand factorJ P Girma, D Meyer, C L Verweij, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|October 22, 1990
Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein IbJ P Girma, Y Takahashi, A Yoshioka, et al.
Blood|September 6, 2001
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 casesA Veyradier, B Obert, A Houllier, et al.
British Journal of Haematology|February 1, 1981
Immunoradiometric assay of factor VIII: coagulant antigen using four human antibodies. Study of 27 cases of haemophilia AJ P Girma, J M Lavergne, D Meyer, et al.
Biochemistry|June 3, 1986
Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domainJ P Girma, M W Chopek, K Titani, et al.
British Journal of Haematology|January 1, 1982
Precipitating anti-VIII:C antibodies in two patients with haemophilia AJ M Lavergne, D Meyer, J P Girma, et al.
Blood|October 1, 1989
New variant of von Willebrand disease with defective binding to factor VIIIM Nishino, J P Girma, C Rothschild, et al.
Blood|February 1, 1984
Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIIIY Laurian, J P Girma, T Lambert, et al.
Thrombosis and Haemostasis|February 1, 1997
Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIIIS Bellucci, J P Girma, M Lozano, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesisA L Jumilly, A Veyradier, A S Ribba, et al.
Blood|September 1, 1987
Structure-function relationship of human von Willebrand factorJ P Girma, D Meyer, C L Verweij, et al.
Pageof 7